Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
Related Posts
U.S. Limits Deadly Mining Dust as Black Lung Resurges
Federal regulators on Tuesday issued new protections for miners against a type of dust long known to cause deadly lung…
After Police Kill Unarmed Black People, Sleep Worsens — but Only for Black People
The new studies on sleep involved federal data from the Behavioral Risk Factor Surveillance System and the American Time Use…
J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices
The chief executives of three major pharmaceutical companies are set to appear in front of the Senate health committee on…
